NO20061468L - Anvendelse av tigecyklin, alene eller i kombinasjonmed rifampin for behandling av osteomyelitt og/eller septisk artritt - Google Patents

Anvendelse av tigecyklin, alene eller i kombinasjonmed rifampin for behandling av osteomyelitt og/eller septisk artritt

Info

Publication number
NO20061468L
NO20061468L NO20061468A NO20061468A NO20061468L NO 20061468 L NO20061468 L NO 20061468L NO 20061468 A NO20061468 A NO 20061468A NO 20061468 A NO20061468 A NO 20061468A NO 20061468 L NO20061468 L NO 20061468L
Authority
NO
Norway
Prior art keywords
joint
combination
infection
rifampin
treatment
Prior art date
Application number
NO20061468A
Other languages
English (en)
Norwegian (no)
Inventor
Jon T Mader
Jason Calhoun
Raymond Thomas Testa
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20061468L publication Critical patent/NO20061468L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Dental Preparations (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Glass Compositions (AREA)
NO20061468A 2003-09-05 2006-03-31 Anvendelse av tigecyklin, alene eller i kombinasjonmed rifampin for behandling av osteomyelitt og/eller septisk artritt NO20061468L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50047403P 2003-09-05 2003-09-05
US10/933,455 US20050148553A1 (en) 2003-09-05 2004-09-03 Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis
PCT/US2004/028980 WO2005023263A1 (en) 2003-09-05 2004-09-07 Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis

Publications (1)

Publication Number Publication Date
NO20061468L true NO20061468L (no) 2006-05-31

Family

ID=36283191

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061468A NO20061468L (no) 2003-09-05 2006-03-31 Anvendelse av tigecyklin, alene eller i kombinasjonmed rifampin for behandling av osteomyelitt og/eller septisk artritt

Country Status (23)

Country Link
US (1) US20050148553A1 (pt)
EP (1) EP1663233B1 (pt)
JP (1) JP2007504249A (pt)
KR (1) KR20060072135A (pt)
CN (1) CN1889957A (pt)
AT (1) ATE401888T1 (pt)
AU (1) AU2004270231A1 (pt)
BR (1) BRPI0413770A (pt)
CA (1) CA2537281A1 (pt)
CO (1) CO5690590A2 (pt)
DE (1) DE602004015307D1 (pt)
DK (1) DK1663233T3 (pt)
EC (1) ECSP066482A (pt)
ES (1) ES2311860T3 (pt)
IL (1) IL173878A0 (pt)
MX (1) MXPA06002414A (pt)
NO (1) NO20061468L (pt)
PL (1) PL1663233T3 (pt)
PT (1) PT1663233E (pt)
RU (1) RU2329047C2 (pt)
SI (1) SI1663233T1 (pt)
UA (1) UA83250C2 (pt)
WO (1) WO2005023263A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7534766B2 (en) * 2004-11-05 2009-05-19 Wyeth Glucuronide metabolites and epimers thereof of tigecycline
CN102512429A (zh) 2005-03-14 2012-06-27 惠氏公司 替加环素组合物及制备方法
KR20080085184A (ko) * 2005-12-22 2008-09-23 와이어쓰 티게사이클린을 사용한 위장관 감염의 치료방법
AU2006331688A1 (en) * 2005-12-22 2007-07-05 Wyeth Oral formulations comprising tigecycline
MD4009C2 (ro) * 2008-07-15 2010-08-31 Институт Химии Академии Наук Молдовы Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
US20120115778A1 (en) * 2009-07-15 2012-05-10 The Trustees Of Columbia University In The City Of New York Methods of Suppressing Appetite by the Administration of Antagonists of the Serotonin HTR1a or HTR2b Receptors or Inhibitors of TPH2
WO2011109899A1 (en) * 2010-03-10 2011-09-15 University Health Network Use of tigecycline for treatment of cancer
RU2454252C1 (ru) * 2010-12-29 2012-06-27 Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО НижГМА Росздрава) Способ профилактики гнойно-септических осложнений (гсо) при операциях на толстой кишке
KR101626544B1 (ko) * 2013-08-07 2016-06-02 서울대학교산학협력단 프롤릴 히드록실라아제 저해제 또는 히스톤 탈아세틸라아제 저해제, 및 항생제를 포함하는 골질환의 예방 또는 치료용 약학적 조성물
US20210369675A1 (en) * 2016-08-20 2021-12-02 John Malcolm Hall Gregg Antimicrobial drug methods of use & therapeutic compositions
CN112843071A (zh) * 2020-09-08 2021-05-28 天津国际生物医药联合研究院 土霉素或者替加环素在抗分枝杆菌感染中的潜在应用
KR102820113B1 (ko) * 2022-06-15 2025-06-12 순천향대학교 산학협력단 골수염 동물 모델 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5494903A (en) * 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
RU2152214C1 (ru) * 1997-06-16 2000-07-10 Нижегородский государственный научно-исследовательский институт травматологии и ортопедии Способ лечения острого остеомиелита
US6582719B2 (en) * 2001-02-02 2003-06-24 The Trustees Of Columbia University In The City Of New York Combinations of antiseptic and antibiotic agents that inhibit the development of resistant microorganisms
GB0114672D0 (en) * 2001-06-15 2001-08-08 Orthogenics As Pharmaceutical formulations and methods of medical treatment
EP2332547A1 (en) * 2001-07-13 2011-06-15 Paratek Pharmaceuticals, Inc. Tetracyclines for the treatment of inflammatory bowel disease
EP1531828A4 (en) * 2002-05-23 2005-11-02 Activbiotics Inc METHODS OF TREATING BACTERIAL INFECTIONS AND ASSOCIATED DISEASES

Also Published As

Publication number Publication date
CA2537281A1 (en) 2005-03-17
BRPI0413770A (pt) 2006-10-31
CN1889957A (zh) 2007-01-03
AU2004270231A1 (en) 2005-03-17
RU2006110936A (ru) 2007-10-10
IL173878A0 (en) 2006-07-05
SI1663233T1 (sl) 2008-12-31
CO5690590A2 (es) 2006-10-31
PL1663233T3 (pl) 2009-05-29
EP1663233A1 (en) 2006-06-07
HK1091754A1 (en) 2007-01-26
ES2311860T3 (es) 2009-02-16
UA83250C2 (ru) 2008-06-25
ECSP066482A (es) 2006-11-24
EP1663233B1 (en) 2008-07-23
WO2005023263A1 (en) 2005-03-17
RU2329047C2 (ru) 2008-07-20
US20050148553A1 (en) 2005-07-07
DE602004015307D1 (de) 2008-09-04
PT1663233E (pt) 2008-10-15
ATE401888T1 (de) 2008-08-15
JP2007504249A (ja) 2007-03-01
MXPA06002414A (es) 2006-08-31
KR20060072135A (ko) 2006-06-27
DK1663233T3 (da) 2008-11-10

Similar Documents

Publication Publication Date Title
MXPA03008623A (es) Combinacion farmaceutica para el tratamiento del cancer.
AP2003002906A0 (en) Crystal forms of azithromycin
PT1420801E (pt) Utilização de fucanos no tratamento de adesões, artrite e psoríase
NO20061468L (no) Anvendelse av tigecyklin, alene eller i kombinasjonmed rifampin for behandling av osteomyelitt og/eller septisk artritt
NZ552047A (en) Method of treatment of endobronchial infections
HUE041133T2 (hu) Dalbavancin adagolási módszer bakteriális fertõzések kezelésére
MD2353C2 (ro) Preparat antibiotic, procedeu de obţinere şi utilizările acestuia
ATE477758T1 (de) Einweg-vorrichtung zur behandlung von infektionen der menschlichen extremitäten
MD2550C2 (ro) Preparat antibiotic cu eliberare lenta a ingredientului activ şi utilizare a acestuia
BR0311948A (pt) Macrociclos de amida antibacterianos
ECSP045397A (es) 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS
UY28542A1 (es) Amidas macrocíclicas antibacterianas
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
NO20043445L (no) Kombinasjonsterapi for behandling av bakterielle infeksjoner
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
MY140519A (en) Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and / or septic arthritis
DE60207884D1 (de) Monobactam-antibakterielle verbindungen und anwendungsverfahren
NO20042711L (no) Fremgangsmate for a behandle bakterielle infeksjoner ved anvendelse av gemifloksasin eller et salt derav et betalaktamantibiotikum
WO2001068675A3 (en) Treatment of rosacea
AU2001276323A1 (en) Use of n-oleoylethanolamine for treating psoriasis
UA42335A (uk) Спосіб лікування гнійних ран
MY140242A (en) BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application